clinvestКачественная клиническая практикаKachestvennaya Klinicheskaya Praktika = Good Clinical Practice2588-05192618-8473ООО «Издательство ОКИclinvest-340Research ArticleНОВЫЕ ЛЕКАРСТВЕННЫЕ СРЕДСТВАNEW DRUGS AND HEALTH TECHNOLOGIESРазработка систем доставки лекарственных средств с применением микро- и наночастицСосновА. В.clinvest@mail.ruИвановР. В.clinvest@mail.ruБалакинК. В.clinvest@mail.ruШоболовД. Л.clinvest@mail.ruФедотовЮ. А.clinvest@mail.ruКалмыковЮ. М.clinvest@mail.ruИсследовательский Институт Химического Разнообразия, Химки, Московская обл.Russian Federation«Технология лекарств», Химки, Московская обл.Russian FederationИсследовательский Институт Химического Разнообразия (ИИХР), Московская область, г. ХимкиRussian Federation20082806201802412Copyright © Соснов А.В., Иванов Р.В., Балакин К.В., Шоболов Д.Л., Федотов Ю.А., Калмыков Ю.М., 20182018Соснов А.В., Иванов Р.В., Балакин К.В., Шоболов Д.Л., Федотов Ю.А., Калмыков Ю.М.Соснов А.В., Иванов Р.В., Балакин К.В., Шоболов Д.Л., Федотов Ю.А., Калмыков Ю.М.Данная работа распространяется под лицензией Creative Commons Attribution 4.0.This work is licensed under a Creative Commons Attribution 4.0 License.https://www.clinvest.ru/jour/article/view/340системы доставки лекарственных средствмикрочастицынаночастицынанотехнологииReferencesDutta R.C. Drug carriers in pharmaceutical design: promises and progress. Curr. Pharm. Des. 2007; 13: 7: 761-769.Dutta R.C. Drug carriers in pharmaceutical design: promises and progress. Curr. Pharm. Des. 2007; 13: 7: 761-769.Caruthers S.D., Wickline S.A., Lanza G.M. Nanotechnological applications in medicine. Curr. Opin. Biotechnol. 2007; 18: 1: 26-30.Caruthers S.D., Wickline S.A., Lanza G.M. Nanotechnological applications in medicine. Curr. Opin. Biotechnol. 2007; 18: 1: 26-30.Euliss L.E., DuPont J.A., Gratton S., DeSimone J. Imparting size, shape, and composition control of materials for nanomedicine. Chem. Soc. Rev. 2006; 35: 11: 1095-104.Euliss L.E., DuPont J.A., Gratton S., DeSimone J. Imparting size, shape, and composition control of materials for nanomedicine. Chem. Soc. Rev. 2006; 35: 11: 1095-104.Medvedeva N.V., Ipatova O.M., Ivanov Iu.D. et al. Nanobiotechnology and nanomedicine. Biomed Khim. 2006; 52: 6: 529-546.Medvedeva N.V., Ipatova O.M., Ivanov Iu.D. et al. Nanobiotechnology and nanomedicine. Biomed Khim. 2006; 52: 6: 529-546.Leoni L., Desai T.A. Nanoporous biocapsules for the encapsulation of insulinoma cells: biotransport and biocompatibility considerations. IEEE Trans. Biomed. Eng. 2001; 48: 11: 1335-1341.Leoni L., Desai T.A. Nanoporous biocapsules for the encapsulation of insulinoma cells: biotransport and biocompatibility considerations. IEEE Trans. Biomed. Eng. 2001; 48: 11: 1335-1341.Onishi H., Machida Y. Macromolecular and nanotechnological modification of camptothecin and its analogs to improve the efficacy. Curr. Drug Discov. Technol. 2005; 2: 3: 169-183.Onishi H., Machida Y. Macromolecular and nanotechnological modification of camptothecin and its analogs to improve the efficacy. Curr. Drug Discov. Technol. 2005; 2: 3: 169-183.Kazakov S., Levon K. Liposome-nanogel structures for future pharmaceutical applications. Curr. Pharm. Des. 2006; 12: 36: 4713-4728.Kazakov S., Levon K. Liposome-nanogel structures for future pharmaceutical applications. Curr. Pharm. Des. 2006; 12: 36: 4713-4728.Bai S., Thomas C., Rawat A., Ahsan F. Recent progress in dendrimer-based nanocarriers. Crit. Rev. Ther. Drug Carrier Syst. 2006; 23: 6: 437-495.Bai S., Thomas C., Rawat A., Ahsan F. Recent progress in dendrimer-based nanocarriers. Crit. Rev. Ther. Drug Carrier Syst. 2006; 23: 6: 437-495.Torchilin V.P. Micellar nanocarriers: pharmaceutical perspectives. Pharm. Res. 2007; 24: 1: 1-16.Torchilin V.P. Micellar nanocarriers: pharmaceutical perspectives. Pharm. Res. 2007; 24: 1: 1-16.Sakaguchi H., Serizawa T., Akashi M. Preparation and characterization of stimuli-resistible hydrogels nano-coated with polyelectrolyte multilayer films. J. Nanosci. Nanotechnol. 2006; 6: 4: 1124-1127.Sakaguchi H., Serizawa T., Akashi M. Preparation and characterization of stimuli-resistible hydrogels nano-coated with polyelectrolyte multilayer films. J. Nanosci. Nanotechnol. 2006; 6: 4: 1124-1127.Nahar M., Dutta T., Murugesan S. et al. Functional polymeric nanoparticles: an efficient and promising tool for active delivery of bioactives. Crit. Rev. Ther. Drug Carrier Syst. 2006; 23: 4: 259-318.Nahar M., Dutta T., Murugesan S. et al. Functional polymeric nanoparticles: an efficient and promising tool for active delivery of bioactives. Crit. Rev. Ther. Drug Carrier Syst. 2006; 23: 4: 259-318.Zakharian T.Y., Seryshev A., Sitharaman B. et al. A fullerene-paclitaxel chemotherapeutic: synthesis, characterization, and study of biological activity in tissue culture. J. Am. Chem. Soc. 2005; 127: 36: 12508-12509.Zakharian T.Y., Seryshev A., Sitharaman B. et al. A fullerene-paclitaxel chemotherapeutic: synthesis, characterization, and study of biological activity in tissue culture. J. Am. Chem. Soc. 2005; 127: 36: 12508-12509.Ebbesen M., Jensen T.G. Nanomedicine: techniques, potentials, and ethical implications. J. Biomed. Biotechnol. 2006; 2006: 5: 51516.Ebbesen M., Jensen T.G. Nanomedicine: techniques, potentials, and ethical implications. J. Biomed. Biotechnol. 2006; 2006: 5: 51516.Pelkmans L., Fava E., Grabner H. et al. Genome-wide analysis of human kinases in clathrin- and caveolae/raft-mediated endocytosis. Nature 2005; 436: 78-86.Pelkmans L., Fava E., Grabner H. et al. Genome-wide analysis of human kinases in clathrin- and caveolae/raft-mediated endocytosis. Nature 2005; 436: 78-86.Geng F., Shen Y., Peng B. et al. Visualization and characterization of drug carrier transportation and distribution in vivo. Conf. Proc. IEEE Eng. Med. Biol. Soc. 2005; 1: 508-11.Geng F., Shen Y., Peng B. et al. Visualization and characterization of drug carrier transportation and distribution in vivo. Conf. Proc. IEEE Eng. Med. Biol. Soc. 2005; 1: 508-11.Manabe N., Hoshino A., Liang Y.Q. et al. Quantum dot as a drug tracer in vivo. IEEE Trans. Nanobioscience. 2006; 5: 4: 263-267.Manabe N., Hoshino A., Liang Y.Q. et al. Quantum dot as a drug tracer in vivo. IEEE Trans. Nanobioscience. 2006; 5: 4: 263-267.
The authors declare that there are no conflicts of interest present.